Feb 24
|
Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect
|
Feb 20
|
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
|
Feb 20
|
Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
Feb 12
|
Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?
|
Feb 11
|
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
|
Oct 2
|
Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
|
Oct 1
|
Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now?
|
Sep 5
|
Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024
|
Sep 5
|
Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy Now
|
Sep 4
|
Jazz Pharmaceuticals Prices $850 Million Senior Notes Offering
|
Sep 4
|
Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases
|
Sep 3
|
Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases
|
Jul 25
|
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting
|
Jul 25
|
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
Jul 24
|
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
|
Jul 23
|
Nanotechnology in medicine: Who are the leading public companies?
|
Jul 9
|
Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer
|
Jun 21
|
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
|
Jun 21
|
Jazz Pharmaceuticals’ essential tremor drug falls flat in Phase IIb trial
|
Jun 20
|
Jazz Dives — But Key Rival Praxis Surges — On Essential Tremor Drug Failure
|